The Global Usher Syndrome Market is estimated to be valued at USD 2.29 Bn in 2025 and is expected to reach USD 3.20 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.9% from 2025 to ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 12, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. – PharmaCorp Rx Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback